101 related articles for article (PubMed ID: 20851116)
21. [Green tea polyphenols inhibit low-density lipoprotein-induced proliferation of rat vascular smooth muscle cells].
Ouyang P; Peng WL; Lai WY; Xu AL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Sep; 24(9):975-9. PubMed ID: 15447839
[TBL] [Abstract][Full Text] [Related]
22. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway.
Fouty BW; Rodman DM
Circ Res; 2003 Mar; 92(5):501-9. PubMed ID: 12600884
[TBL] [Abstract][Full Text] [Related]
23. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
24. Tanshinone IIA inhibits smooth muscle proliferation and intimal hyperplasia in the rat carotid balloon-injured model through inhibition of MAPK signaling pathway.
Li X; Du JR; Yu Y; Bai B; Zheng XY
J Ethnopharmacol; 2010 May; 129(2):273-9. PubMed ID: 20363310
[TBL] [Abstract][Full Text] [Related]
25. Dysfunction of vascular smooth muscle and vascular remodeling by simvastatin.
Kang S; Woo HH; Kim K; Lim KM; Noh JY; Lee MY; Bae YM; Bae ON; Chung JH
Toxicol Sci; 2014 Apr; 138(2):446-556. PubMed ID: 24449418
[TBL] [Abstract][Full Text] [Related]
26. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture.
Guijarro C; Blanco-Colio LM; Ortego M; Alonso C; Ortiz A; Plaza JJ; Díaz C; Hernández G; Egido J
Circ Res; 1998 Sep; 83(5):490-500. PubMed ID: 9734471
[TBL] [Abstract][Full Text] [Related]
27. [Novel actions of HMG-CoA reductase inhibitors(statins)--vascular and cerebral protection through inhibition of small GTPase Rho].
Sawada N; Itoh H; Nakao K
Nihon Rinsho; 2001 Dec; 59(12):2470-5. PubMed ID: 11766357
[TBL] [Abstract][Full Text] [Related]
28. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells.
Ito T; Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Shimada K
Cardiovasc Drugs Ther; 2002 Mar; 16(2):121-6. PubMed ID: 12090904
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells.
Ichiki T; Takeda K; Tokunou T; Iino N; Egashira K; Shimokawa H; Hirano K; Kanaide H; Takeshita A
Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1896-901. PubMed ID: 11742861
[TBL] [Abstract][Full Text] [Related]
30. Regulation of interleukin-8 expression by HMG-CoA reductase inhibitors in human vascular smooth muscle cells.
Ito T; Ikeda U; Yamamoto K; Shimada K
Atherosclerosis; 2002 Nov; 165(1):51-5. PubMed ID: 12208470
[TBL] [Abstract][Full Text] [Related]
31. Influence of HMG-CoA reductase inhibitors on leptin-induced endothelial cell proliferation, migration, and capillary-like tube formation.
Burgazli KM; Stein NI; Mericliler M; Parahuleva M; Erdogan A
Postgrad Med; 2014 May; 126(3):231-8. PubMed ID: 24918807
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.
Ali OF; Growcott EJ; Butrous GS; Wharton J
Respir Res; 2011 Oct; 12(1):137. PubMed ID: 21999923
[TBL] [Abstract][Full Text] [Related]
33. Fluvastatin enhances apoptosis in cytokine-stimulated vascular smooth muscle cells.
Takahashi M; Ogata Y; Okazaki H; Takeuchi K; Kobayashi E; Ikeda U; Shimada K
J Cardiovasc Pharmacol; 2002 Feb; 39(2):310-7. PubMed ID: 11791017
[TBL] [Abstract][Full Text] [Related]
34. Lipophilic statins induce apoptosis of human vascular smooth muscle cells.
Guijarro C; Blanco-Colio LM; Massy ZA; O'Donnell MP; Kasiske BL; Keane WF; Egido J
Kidney Int Suppl; 1999 Jul; 71():S88-91. PubMed ID: 10412746
[TBL] [Abstract][Full Text] [Related]
35. Effects of statins on vascular function of endothelin-1.
Mraiche F; Cena J; Das D; Vollrath B
Br J Pharmacol; 2005 Mar; 144(5):715-26. PubMed ID: 15678081
[TBL] [Abstract][Full Text] [Related]
36. Effect of the new HMG-CoA reductase inhibitor cerivastatin (BAY W 6228)on migration, proliferation and cholesterol synthesis in arterial myocytes.
Corsini A; Arnaboldi L; Raiteri M; Quarato P; Faggiotto A; Paoletti R; Fumagalli R
Pharmacol Res; 1996 Jan; 33(1):55-61. PubMed ID: 8817647
[TBL] [Abstract][Full Text] [Related]
37. Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC.
Bergman M; Salman H; Djaldetti M; Bessler H
Vascul Pharmacol; 2011; 54(3-6):88-92. PubMed ID: 21440087
[TBL] [Abstract][Full Text] [Related]
38. Pleiotropic effects of statins on the vascular tissue.
Ikeda U; Shimada K
Curr Drug Targets Cardiovasc Haematol Disord; 2001 Jun; 1(1):51-8. PubMed ID: 12769664
[TBL] [Abstract][Full Text] [Related]
39. All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells.
Kaneta S; Satoh K; Kano S; Kanda M; Ichihara K
Atherosclerosis; 2003 Oct; 170(2):237-43. PubMed ID: 14612203
[TBL] [Abstract][Full Text] [Related]
40. Statins with different lipophilic indices exert distinct effects on skeletal, cardiac and vascular smooth muscle.
Irwin JC; Fenning AS; Vella RK
Life Sci; 2020 Feb; 242():117225. PubMed ID: 31881229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
